Dx & Vx Co., Ltd.

Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.

180400 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 서울특별시 금천구 디지털로 173, 금천구
Website:: https://www.dxvx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dx & Vx Co., Ltd. is a global bio-healthcare company focused on developing innovative diagnostics (Dx) and vaccines (Vx). The company leverages proprietary technologies, including a platform for long-term, room-temperature storage of mRNA vaccines and a universal Next-Generation Sequencing (NGS) platform. Its R&D pipeline targets infectious diseases, immuno-oncology, obesity, and eye diseases. In addition to its drug development, Dx & Vx provides a comprehensive suite of services to the life sciences industry, including contract development (CDO), manufacturing (CMO), sales (CSO), and companion diagnostics (CDx) development. The company also develops microbiome-based products and offers medical data services.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Dx & Vx Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Dx & Vx Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Dx & Vx Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
AcuCort AB Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.	Sweden	ACUC
ADBIOTECH Co.,Ltd. Develops egg-based IgY antibodies as vaccine/antibiotic alternatives for animal and human health.	South Korea	179530
Advicenne Develops and commercializes therapies for rare renal diseases for patients of all ages.	France	ALDVI
AegirBio AB Develops user-friendly, saliva-based tests for health monitoring & therapeutic drug monitoring.	Sweden	AEGIR
Aelis Farma Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.	France	AELIS
AFC-HD AMS Life Science Co.,Ltd. An OEM of health foods, supplements, and cosmetics, managing the full value chain from R&D to sales.	Japan	2927
ALK-Abelló Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.	Denmark	ALK
Alkaloid AD Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.	North Macedonia	ALK
ALLERGY THERAPEUTICS PLC Develops innovative, aluminum-free allergy immunotherapy vaccines for the European market.	United Kingdom	AGY
Alligator Bioscience Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.	Sweden	ATORX